Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
50.00
-2.97 (-5.61%)
At close: Apr 1, 2025, 4:00 PM
48.21
-1.79 (-3.58%)
After-hours: Apr 1, 2025, 7:50 PM EDT

Rhythm Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-260.6-184.68-181.12-69.61-134
Upgrade
Depreciation & Amortization
1.561.761.671.160.69
Upgrade
Loss (Gain) From Sale of Investments
-8.17-9.84-2.31--
Upgrade
Loss (Gain) on Equity Investments
--1.04--
Upgrade
Stock-Based Compensation
39.6832.5519.8320.817.46
Upgrade
Other Operating Activities
103.0719.244.87-100.25-0.23
Upgrade
Change in Accounts Receivable
-3.65-8.64-5.2-1.25-
Upgrade
Change in Inventory
-10.12-5.71-2.81-0.01-
Upgrade
Change in Accounts Payable
21.9214.771.5418.31-6.45
Upgrade
Change in Unearned Revenue
--0.15-6.61--
Upgrade
Change in Other Net Operating Assets
2.424.53-4.34-15.150.55
Upgrade
Operating Cash Flow
-113.88-136.16-173.43-146-121.98
Upgrade
Capital Expenditures
--0.05-0.28-0.43-0.21
Upgrade
Sale (Purchase) of Intangibles
-40.5-5.67-7-
Upgrade
Investment in Securities
-7.670.0532.31-163.73158.75
Upgrade
Other Investing Activities
---495-
Upgrade
Investing Cash Flow
-48.17-5.6728.03-62.16158.53
Upgrade
Issuance of Common Stock
56.3957.4141.49166.482.01
Upgrade
Other Financing Activities
-416.9772.34--
Upgrade
Financing Cash Flow
191.2474.37213.83166.482.01
Upgrade
Foreign Exchange Rate Adjustments
0-0.14---
Upgrade
Net Cash Flow
29.19-67.668.43-41.6838.56
Upgrade
Free Cash Flow
-113.88-136.2-173.71-146.44-122.19
Upgrade
Free Cash Flow Margin
-87.51%-175.91%-734.87%-4642.90%-
Upgrade
Free Cash Flow Per Share
-1.87-2.36-3.33-2.95-2.77
Upgrade
Levered Free Cash Flow
-139.74-91.47-105.11-57.05-72.85
Upgrade
Unlevered Free Cash Flow
-126.86-82.79-101.86-57.05-72.85
Upgrade
Change in Net Working Capital
-38.33-3.8311.11-20.715.42
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q